SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-022668
Filing Date
2024-07-12
Accepted
2024-07-12 16:37:50
Documents
17
Period of Report
2024-07-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K zvra20240711_8k.htm   iXBRL 8-K 40300
2 EXHIBIT 1.1 ex_697545.htm EX-1.1 259050
3 EXHIBIT 5.1 ex_697480.htm EX-5.1 13972
8 lw2.jpg GRAPHIC 5379
  Complete submission text file 0001437749-24-022668.txt   515743

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA zvra-20240712.xsd EX-101.SCH 3409
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE zvra-20240712_def.xml EX-101.DEF 11424
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE zvra-20240712_lab.xml EX-101.LAB 15310
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zvra-20240712_pre.xml EX-101.PRE 11584
19 EXTRACTED XBRL INSTANCE DOCUMENT zvra20240711_8k_htm.xml XML 2849
Mailing Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747
Business Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747 (321) 939-3416
ZEVRA THERAPEUTICS, INC. (Filer) CIK: 0001434647 (see all company filings)

IRS No.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36913 | Film No.: 241114952
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)